Vault-13

Sivik Global Healthcare LLC

GREENWICH, CT · CIK 1596452 · 13F filing filed 2023-08-09

SEC-registered investment adviser since 2014 · limited liability company

$250.2m reported value +7.6% vs Q1 2023
42positions
38.9%in top 10
7 new 15 added 15 reduced 5 sold out vs Q1 2023

Options: 0 call positions (— notional), 1 put positions ($177.3m notional) – listed below, not included above.

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SPDR SER TR S&P BIOTECH XBI XBI 250,000 $20.8m8.31% 8.31% AddedShares held: Q3 2022 11.3k, Q4 2022 175.0k, Q1 2023 200.0k, Q2 2023 250.0k +50.0k +50,000 25.0%
2 TENET HEALTHCARE CORP COM NEW THC THC 140,000 $11.4m4.55% 4.55% ReducedShares held: Q3 2022 120.0k, Q4 2022 165.0k, Q1 2023 150.0k, Q2 2023 140.0k -10.0k -10,000 -6.7%
3 BOSTON SCIENTIFIC CORP COM BSX BSX 160,000 $8.7m3.46% 3.46% AddedShares held: Q3 2022 185.0k, Q4 2022 185.0k, Q1 2023 155.0k, Q2 2023 160.0k +5.0k +5,000 3.2%
4 UNIVERSAL HLTH SVCS INC CL B UHS UHS 52,500 $8.3m3.31% 3.31% ReducedShares held: Q3 2022 65.0k, Q4 2022 55.0k, Q1 2023 55.0k, Q2 2023 52.5k -2.5k -2,490 -4.5%
5 ELI LILLY & CO COM LLY LLY 17,500 $8.2m3.28% 3.28% ReducedShares held: Q3 2022 17.5k, Q4 2022 17.5k, Q1 2023 20.0k, Q2 2023 17.5k -2.5k -2,500 -12.5%
6 NOVO-NORDISK A S ADR NVO NVO 50,000 $8.1m3.23% 3.23% ReducedShares held: Q3 2022 40.0k, Q4 2022 50.0k, Q1 2023 60.0k, Q2 2023 50.0k -10.0k -10,000 -16.7%
7 CARDINAL HEALTH INC COM CAH CAH 85,000 $8.0m3.21% 3.21% AddedShares held: Q3 2022 80.0k, Q4 2022 70.0k, Q1 2023 80.0k, Q2 2023 85.0k +5.0k +5,000 6.2%
8 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 55,000 $8.0m3.20% 3.20% ReducedShares held: Q3 2022 60.0k, Q4 2022 60.0k, Q1 2023 60.0k, Q2 2023 55.0k -5.0k -5,000 -8.3%
9 BECTON DICKINSON & CO COM BDX BDX 30,000 $7.9m3.17% 3.17% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 15.0k, Q2 2023 30.0k +15.0k +15,000 100.0%
10 SURGERY PARTNERS INC COM SGRY SGRY 175,000 $7.9m3.15% 3.15% UnchangedShares held: Q3 2022 138.6k, Q4 2022 165.0k, Q1 2023 175.0k, Q2 2023 175.0k
11 HUMANA INC COM HUM HUM 17,500 $7.8m3.13% 3.13% ReducedShares held: Q3 2022 10.5k, Q4 2022 13.0k, Q1 2023 22.5k, Q2 2023 17.5k -5.0k -5,000 -22.2%
12 CENCORA INC COM COR COR 40,000 $7.7m3.08% 3.08% UnchangedShares held: Q3 2022 30.0k, Q4 2022 30.0k, Q1 2023 40.0k, Q2 2023 40.0k
13 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 22,500 $7.7m3.08% 3.08% ReducedShares held: Q3 2022 30.0k, Q4 2022 30.0k, Q1 2023 30.0k, Q2 2023 22.5k -7.5k -7,500 -25.0%
14 STRYKER CORPORATION COM SYK SYK 25,000 $7.6m3.05% 3.05% UnchangedShares held: Q3 2022 30.5k, Q4 2022 35.0k, Q1 2023 25.0k, Q2 2023 25.0k
15 HCA HEALTHCARE INC COM HCA HCA 25,000 $7.6m3.03% 3.03% ReducedShares held: Q3 2022 42.5k, Q4 2022 35.0k, Q1 2023 30.0k, Q2 2023 25.0k -5.0k -5,000 -16.7%
16 MCKESSON CORP COM MCK MCK 17,500 $7.5m2.99% 2.99% AddedShares held: Q3 2022 17.5k, Q4 2022 15.0k, Q1 2023 15.0k, Q2 2023 17.5k +2.5k +2,500 16.7%
17 BAXTER INTL INC COM BAX BAX 160,000 $7.3m2.91% 2.91% AddedShares held: Q3 2022 120.0k, Q4 2022 150.0k, Q1 2023 150.0k, Q2 2023 160.0k +10.0k +10,000 6.7%
18 ENCOMPASS HEALTH CORP COM EHC EHC 99,976 $6.8m2.71% 2.71% AddedShares held: Q3 2022 85.0k, Q4 2022 85.0k, Q1 2023 55.0k, Q2 2023 100.0k +45.0k +44,976 81.8%
19 ELEVANCE HEALTH INC COM ELV ELV 15,000 $6.7m2.66% 2.66% AddedShares held: Q3 2022 11.0k, Q4 2022 8.0k, Q1 2023 10.5k, Q2 2023 15.0k +4.5k +4,457 42.3%
20 ABBOTT LABS COM ABT ABT 60,000 $6.5m2.61% 2.61% AddedShares held: Q3 2022 30.0k, Q4 2022 45.0k, Q1 2023 45.0k, Q2 2023 60.0k +15.0k +15,000 33.3%
21 IQVIA HLDGS INC COM IQV IQV 27,500 $6.2m2.47% 2.47% AddedShares held: Q3 2022 10.0k, Q4 2022 15.0k, Q1 2023 20.0k, Q2 2023 27.5k +7.5k +7,500 37.5%
22 SELECT MED HLDGS CORP COM SEM SEM 190,000 $6.1m2.42% 2.42% AddedShares held: Q3 2022 130.0k, Q4 2022 100.0k, Q1 2023 107.8k, Q2 2023 190.0k +82.2k +82,162 76.2%
23 DANAHER CORPORATION COM DHR DHR 25,000 $6.0m2.40% 2.40% AddedShares held: Q3 2022 25.0k, Q4 2022 20.0k, Q1 2023 20.0k, Q2 2023 25.0k +5.0k +5,000 25.0%
24 MERCK & CO INC COM MRK MRK 50,000 $5.8m2.31% 2.31% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 75.0k, Q2 2023 50.0k -25.0k -25,000 -33.3%
25 THE CIGNA GROUP COM CI CI 20,000 $5.6m2.24% 2.24% AddedShares held: Q3 2022 25.0k, Q4 2022 20.0k, Q1 2023 15.0k, Q2 2023 20.0k +5.0k +5,000 33.3%
26 MEDTRONIC PLC SHS MDT MDT 60,000 $5.3m2.11% 2.11% ReducedShares held: Q3 2022 30.0k, Q4 2022 0, Q1 2023 67.5k, Q2 2023 60.0k -7.5k -7,500 -11.1%
27 ICON PLC SHS ICLR ICLR 20,000 $5.0m2.00% 2.00% AddedShares held: Q3 2022 0, Q4 2022 15.0k, Q1 2023 15.0k, Q2 2023 20.0k +5.0k +5,000 33.3%
28 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 14,000 $4.9m1.97% 1.97% ReducedShares held: Q3 2022 0, Q4 2022 15.0k, Q1 2023 15.0k, Q2 2023 14.0k -1.0k -1,000 -6.7%
29 UNITEDHEALTH GROUP INC COM UNH UNH 10,000 $4.8m1.92% 1.92% ReducedShares held: Q3 2022 12.0k, Q4 2022 8.0k, Q1 2023 17.5k, Q2 2023 10.0k -7.5k -7,500 -42.9%
30 ACADIA HEALTHCARE COMPANY IN COM ACHC ACHC 60,000 $4.8m1.91% 1.91% ReducedShares held: Q3 2022 70.0k, Q4 2022 70.0k, Q1 2023 70.0k, Q2 2023 60.0k -10.0k -10,000 -14.3%
31 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 50,000 $4.3m1.73% 1.73% UnchangedShares held: Q3 2022 55.0k, Q4 2022 60.0k, Q1 2023 50.0k, Q2 2023 50.0k
32 THERMO FISHER SCIENTIFIC INC COM TMO TMO 7,500 $3.9m1.56% 1.56% ReducedShares held: Q3 2022 15.0k, Q4 2022 11.0k, Q1 2023 11.0k, Q2 2023 7.5k -3.5k -3,500 -31.8%
33 CATALENT INC COM CTLT CTLT 70,000 $3.0m1.21% 1.21% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 70.0k
34 BIOGEN INC COM BIIB BIIB 10,000 $2.8m1.14% 1.14% UnchangedShares held: Q3 2022 10.0k, Q4 2022 10.0k, Q1 2023 10.0k, Q2 2023 10.0k
35 CHARLES RIV LABS INTL INC COM CRL CRL 13,000 $2.7m1.09% 1.09% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 13.0k
36 STEVANATO GROUP S P A ORD SHS STVN STVN 70,000 $2.3m0.91% 0.91% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 70.0k
37 AVANTOR INC COM AVTR AVTR 75,000 $1.5m0.62% 0.62% NewShares held: Q3 2022 100.0k, Q4 2022 0, Q1 2023 0, Q2 2023 75.0k
38 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 8,000 $1.5m0.61% 0.61% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 7.5k, Q2 2023 8.0k +500 +500 6.7%
39 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 300,000 $1.3m0.53% 0.53% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 300.0k
40 ARGENX SE SPONSORED ADR ARGX ARGX 3,000 $1.2m0.47% 0.47% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 3.0k
41 GRIFOLS S A SP ADR REP B NVT GRFS GRFS 62,843 $576.0k0.23% 0.23% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 62.8k
42 SAREPTA THERAPEUTICS INC COM SRPT SRPT 811 $93.0k0.04% 0.04% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 13.0k, Q2 2023 811 -12.2k -12,189 -93.8%

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
ABBVIE INC ABBV ABBV 40,000 $6.4m40.0k shares
AGILENT TECHNOLOGIES INC A A 40,000 $5.5m40.0k shares
WATERS CORP WAT WAT 15,000 $4.6m15.0k shares
SEAGEN INC SGEN SGEN 16,000 $3.2m16.0k shares
OPTION CARE HEALTH INC OPCH OPCH 80,000 $2.5m80.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR S&P 500 ETF TR SPY · Put SPYPut 400,000 $177.3m400.0k shares New